3,4-Diisopropoxy-3-cyclobutene-1,2-dione, 98.0%, 10g

(4-((4-Chlorobenzyl)oxy)phenyl)boronic acid, 95%, 1g

2,3-Dichloro-4-ethoxyphenylboronic acid, 97%, 1g

tert-Butyl ((3S,5R)-5-fluoropiperidin-3-yl)carbamate, 95.0%, 500mg

Benzoic acid, 4-(aminomethyl)-3-fluoro-, methyl ester, hydrochloride (1:1), 100mg

2-(4-Methoxyphenyl)acetophenone, 97.0%, 250mg

n-(2-Aminoethyl)-2-nitrobenzene-1-sulfonamide hydrochloride, 98%, 1g

5-bromo-2-(4H-1,2,4-triazol-4-yl)pyridine, 95.0%, 5g

N-(2-Methoxybenzyl)oxetan-3-yl-amine, >95%, 1g

Methyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 1g

[2-(4-fluorophenoxy)ethyl]amine methanesulfonate, 95.0%, 5g

Colonna capillare per GC ROTI®Cap-1701, 60 m, 0,32 mm, 0,25 µm, 1 Pezzo(i)

7-Hydroxyquinoline, 98.00%, 25g